Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus. 1990

M Yasuma, and Y Takasaki, and K Matsumoto, and A Kodama, and H Hashimoto, and S Hirose
Department of Internal Medicine, Juntendo University, School of Medicine, Tokyo, Japan.

Free Sm was purified by gel filtration and anti-Sm affinity chromatography. Using this purified antigen, an ELISA for anti-Sm was performed. Three hundred and fifty patients with various rheumatic diseases were studied with respect to immunoglobulin classes of anti-Sm by ELISA. A high frequency of IgG anti-Sm was specifically detected in patients with systemic lupus erythematosus (SLE), but IgA and IgM anti-Sm showed a low frequency and also was detected in other diseases. In patients with SLE, anti-Sm significantly correlated with lung fibrosis and pericarditis. In our longitudinal study, there were increases in titer of IgG anti-Sm preceding central nervous system exacerbation and serositis. IgG anti-Sm was found to be not only a diagnostic marker but also a reliable measure of disease activity in SLE.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Yasuma, and Y Takasaki, and K Matsumoto, and A Kodama, and H Hashimoto, and S Hirose
February 1983, The American journal of medicine,
M Yasuma, and Y Takasaki, and K Matsumoto, and A Kodama, and H Hashimoto, and S Hirose
June 2002, Zeitschrift fur Rheumatologie,
M Yasuma, and Y Takasaki, and K Matsumoto, and A Kodama, and H Hashimoto, and S Hirose
May 1997, Revista clinica espanola,
M Yasuma, and Y Takasaki, and K Matsumoto, and A Kodama, and H Hashimoto, and S Hirose
June 1991, The Indian journal of medical research,
M Yasuma, and Y Takasaki, and K Matsumoto, and A Kodama, and H Hashimoto, and S Hirose
January 2017, Clinical and experimental rheumatology,
M Yasuma, and Y Takasaki, and K Matsumoto, and A Kodama, and H Hashimoto, and S Hirose
March 1997, American journal of hematology,
M Yasuma, and Y Takasaki, and K Matsumoto, and A Kodama, and H Hashimoto, and S Hirose
September 2010, Annals of the rheumatic diseases,
M Yasuma, and Y Takasaki, and K Matsumoto, and A Kodama, and H Hashimoto, and S Hirose
September 1998, The Journal of rheumatology,
M Yasuma, and Y Takasaki, and K Matsumoto, and A Kodama, and H Hashimoto, and S Hirose
January 2022, Journal of translational autoimmunity,
M Yasuma, and Y Takasaki, and K Matsumoto, and A Kodama, and H Hashimoto, and S Hirose
June 2000, The Journal of rheumatology,
Copied contents to your clipboard!